| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President And CEO
1 company
Crockett Thomas Andrew is a CEO at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sale+OE | 1,797 | $14.96 | $26,890.49 | -1.6% | -65.7% | -28.1% | |
| Mar 9, 2022 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $17.07 | $170,693.00 | -8.0% | -47.8% | -56.7% | |
| Oct 1, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $17.18 | $171,841.00 | -7.4% | -21.6% | -16.3% | |
| Jul 1, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $24.15 | $241,476.96 | -3.5% | -30.1% | -59.6% | |
| Jun 17, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 1,067 | $30.04 | $32,050.55 | -0.7% | -35.6% | -69.5% | |
| Jun 9, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 8,933 | $30.05 | $268,480.42 | -5.8% | -30.0% | -70.8% | |
| Apr 1, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $27.44 | $274,436.23 | -2.0% | -12.7% | -45.4% | |
| Feb 23, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $33.55 | $335,538.32 | -1.4% | - | - | |
| Jan 4, 2021 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $18.19 | $181,904.14 | -2.6% | - | - | |
| Oct 21, 2020 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 38,539 | $17.98 | $693,025.16 | -3.5% | - | - |